Disclosed is a compound of formula (I) e.g. N-(6-Acetylamino-7,8-dihydro-6H-pyrrolo[2,1 ,2,3]imidazo[4,5-b]pyridin-3-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide in which the substituents are defined in the specification in the form of a base or addition salt with an acid, and in the form of a hydrate or solvate for preventing or treating pain, inflammation, metabolic disorders, urological disorders, gynaecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritis, dermal ocular or mucosal irritation, herpes, shingles, depression or diseases of the central nervous system.
